PRAC meeting highlights 26 - 29 October 2026

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) is responsible for assessing and monitoring safety issues for human medicines.

Highlights from the November 2026 meeting are now available on the EMA website